Table 1.

Beneficence/non maleficence deep brain stimulation.

PD/ET DBS Adverse Events (AE)	Frequency
DBS Tremor study n = 424
Patient with ≥1 device/surgery AE (i.e. 7% postoperative pain)	28%
Patients ≥ 1 stimulation AE (i.e. paresthesia 33%)	40%
Death , DBS-related	0.7% *
DBS PD study n = 160
Patients ≥ 1 device AE	96.3%
Stimulation adverse events	51.9%
Device adverse events	36.9%
Ongoing stimulation adverse events	22.5%
Ongoing device adverse events	10.0%
Stimulation serious adverse events	9.4%
Device serious adverse events	17.5%
Serious ongoing stimulation AE	3.1%
Serious ongoing device AE	6.3%
Infection	10.6%*
Paresis/asthenia	10.0%
Hemiplegia/hemiparesis	8.1%
Intracranial hemorrhage	7.5%*
Death , DBS-related	0.6% *

^*Life threatening; (Medtronic 2015).